XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue:      
Premium revenue $ 26,855 $ 18,299 $ 16,208
Premium tax revenue 787 649 489
Health insurer fees reimbursed 0 271 0
Marketplace risk corridor judgment 0 128 0
Investment income 52 59 115
Other revenue 77 17 17
Total revenue 27,771 19,423 16,829
Operating expenses:      
Medical care costs 23,704 15,820 13,905
General and administrative expenses 2,068 1,480 1,296
Premium tax expenses 787 649 489
Health insurer fees 0 277 0
Depreciation and amortization 131 88 89
Other 61 31 6
Total operating expenses 26,751 18,345 15,785
Total operating expenses 1,020 1,078 1,044
Other expenses, net:      
Interest expense 120 102 87
Other expenses (income), net 25 15 (15)
Total other expenses, net 145 117 72
Income before income tax expense 875 961 972
Income tax expense 216 288 235
Net income $ 659 $ 673 $ 737
Net income per share:      
Basic (in dollars per share) $ 11.40 $ 11.40 $ 11.85
Diluted (in dollars per share) $ 11.25 $ 11.23 $ 11.47
Weighted average shares outstanding:      
Basic (in shares) 57.8 59.0 62.2
Diluted (in shares) 58.6 59.9 64.2